My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions, conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts.
About Us
Plans & Pricing
Emmaus Life Sciences Inc (EMMA)
OTHER OTC:EMMA
EMMA other otc
United States
Emmaus Life Sciences

Emmaus Life Sciences Stock Analysis & Ratings

Emmaus Life Sciences Stock Analysis Overview

Smart Score
N/A
Not Ranked
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.

Stock Chart

EMMA

EMMA Stock Stats

Previous Close$1.56
Open$1.56
Bid0 x 0
Ask0 x 0
Today’s Range$1.55 - $1.65
52-Week Range$1.01 - $4.00
Volume13.65K
Average Volume17.53K
Market Cap$81.36M
Beta2.18
P/E Ratio-8.2
EPS-0.19
Earnings DateNov 12, 2021

Company Description

Emmaus Life Sciences Inc

Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company. It engages in the discovery, development, marketing and sale of innovative treatments and therapies, including those in the rare and orphan disease categories. The company is headquartered in Torrance, CA.
Sector
Healthcare
Industry
Biotechnology
CEO
N/A
Employees
58
ISIN
US29137T1016
Address
21250 Hawthorne Boulevard, Torrance, CA, 90503, US

Financials


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

EMMA FAQ

What was Emmaus Life Sciences’s price range in the past 12 months?
Emmaus Life Sciences lowest stock price was $1.01 and its highest was $4.00 in the past 12 months.
    What is Emmaus Life Sciences’s market cap?
    Emmaus Life Sciences’s market cap is $81.36M.
      What is Emmaus Life Sciences’s price target?
      Currently, no data Available
      What do analysts say about Emmaus Life Sciences?
      Not enough analysts have published a price target to provide an average price target.
      When is Emmaus Life Sciences’s upcoming earnings report date?
      Emmaus Life Sciences’s upcoming earnings report date is Nov 12, 2021 which is 27 days ago.
        How were Emmaus Life Sciences’s earnings last quarter?
        Emmaus Life Sciences released its earnings results on Jan 25, 2021. The company reported -$0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.005.
          Is Emmaus Life Sciences overvalued?
          According to Wall Street analysts Emmaus Life Sciences’s price is currently Overvalued.
            Does Emmaus Life Sciences pay dividends?
            Emmaus Life Sciences does not currently pay dividends.
            What is Emmaus Life Sciences’s EPS estimate?
            Emmaus Life Sciences’s EPS estimate is -$0.06.
              How many shares outstanding does Emmaus Life Sciences have?
              Emmaus Life Sciences has 49,310,000 shares outstanding.
                What happened to Emmaus Life Sciences’s price movement after its last earnings report?
                Emmaus Life Sciences reported an EPS of -$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.667%.
                  Which hedge fund is a major shareholder of Emmaus Life Sciences?
                  Currently, no hedge funds are holding shares in EMMA

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis